Takara Bio Inc.TSE: 4974

Notice regarding Partial Correction of the Notice of the Extraordinary Shareholders’ Meeting

· Issued by Takara Bio Inc.

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the Japanese original shall prevail.

To our shareholders:

(Securities Code: 4974)

May 8, 2026

Tsuyoshi Miyamura, President & CEO

Takara Bio Inc.

7-4-38, Nojihigashi, Kusatsu-shi, Shiga

Notice regarding Partial Correction of the Notice of the Extraordinary Shareholders’ Meeting

With reference to the “Notice of the Extraordinary Shareholders’ Meeting” of Takara Bio Inc. (the “Company”), we hereby inform you that certain items in the “Reference Documents for the Extraordinary General Meeting of Shareholders” require correction. We sincerely apologize for any inconvenience this may cause and hereby announce the details of such corrections as set forth below.

Please note that the “Notice of the Extraordinary Shareholders’ Meeting” posted on the Company’s website and the Tokyo Stock Exchange website has been updated to reflect the corrected content.

  1. Location of Correction:

    Notice of the Extraordinary Shareholders’ Meeting (page 54)

    Reference Documents for the Extraordinary General Meeting of Shareholders Proposal No. 2: Partial Amendments to the Articles of Incorporation

  2. Details of Correction:

The details of the correction are as follows. Corrected portions are underlined.

  1. Reasons for the Amendments

(omitted)

(2) If Proposal No. 1 is approved and adopted as originally proposed at the Extraordinary Shareholders’ Meeting and the Share Consolidation becomes effective, the total number of issued shares of the Company will be 24shares, and there will be no need to provide for the number of shares in one unit. Therefore, on the condition that the Share Consolidation becomes effective, in order to abolish the provisions regarding the number of shares in one unit of the Company Share, which specifies that the number of shares in one unit shall be 100 shares, the Company proposes to entirely delete Article 7 (Number of Shares in One Unit) of the Articles of Incorporation and renumber the subsequent articles accordingly.

(omitted)

1. Reasons for the Amendments

(omitted)

(2) If Proposal No. 1 is approved and adopted as originally proposed at the Extraordinary Shareholders’ Meeting and the Share Consolidation becomes effective, the total number of issued shares of the Company will be 6shares, and there will be no need to provide for the number of shares in one unit. Therefore, on the condition that the Share Consolidation becomes effective, in order to abolish the provisions regarding the number of shares in one unit of the Company Share, which specifies that the number of shares in one unit shall be 100 shares, the Company proposes to entirely delete Article 7 (Number of Shares in One Unit) of the Articles of Incorporation and renumber the subsequent articles accordingly.

(omitted)

End

Company analysis

Earlier from Takara Bio

All Takara Bio news releases